日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Europe

EU backs AstraZeneca COVID-19 vaccine as blood clot reviews continue

Updated: 2021-04-24 05:47
Share
Share - WeChat
[Photo/Agencies]

April 23 - Europe's drug regulator reiterated on Friday the benefits of AstraZeneca's COVID-19 vaccine outweigh any risks, delivering an assessment based on continuing reviews into rare blood clots to help countries determine the shot's use.

The renewed backing comes after several countries in the European Union and worldwide have limited the use of the vaccine, known as Vaxzevria. Denmark has stopped its use altogether, after possible links to clotting issues in combination with low platelet levels were confirmed.

The interim analysis by a committee of the European Medicines Agency (EMA) determined that serious side effects of rare blood clots are likely to occur in 1 out of 100,000 vaccinated people, the regulator said in a statement.

EMA officials said in a briefing the update on Friday was aimed at putting into context the data it has collected and analysed to help 27 EU member states work out how to use the shot based on their local situations.

The advantages of getting the vaccine increase with age and with any rise in infections rates, but the benefits were for now evident across all scenarios and ages, the officials said.

They said the recommendation may be subject to change because more data is being collected, and for instance not all EU member states had included the sex of the vaccine recipients in their data.

But Peter Arlett, head of EMA's data analytics and methods task force, said: "The benefit risk balance of the AstraZeneca vaccine is positive. It's preventing serious disease and saving lives."

Earlier this month, the EMA said it had found a possible link between AstraZeneca's coronavirus vaccine and a similar, rare blood clotting problem connected to the one from Johnson & Johnson which led to a small number of deaths.

There was not enough data on Vaxzevria from Europe to determine if blood clot risks with low blood platelets would differ with each dose of the vaccine, or to provide context on its benefits and risks with regards to gender, the EMA said.

Countries are also in the midst of determining whether to use J&J's vaccine over concerns about blood clots and U.S. regulators were meeting on Friday to consider whether it is safe to resume J&J injections.

Regulators have found these events occurred mostly in the brain and abdomen.

(Reporting by Pushkala Aripaka in Bengaluru, Ludwig Burger in Frankfurt, Alistair Smout and Keith Weir in London; Writing by Josephine Mason; Editing by Saumyadeb Chakrabarty and Sriraj Kalluvila, William Maclean)

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 福利片在线 | 国产区二区 | 亚洲午夜电影 | 日韩高清成人 | 国产在线精品二区韩国演艺界 | k8久久久一区二区三区 | 久久午夜电影网 | 黄网免费看| 电视剧全部免费观看 | 欧美影院推理片免费看 | 亚洲欧美精品 | 激情五月在线 | 草久久免费视频 | 国内自拍偷拍网 | 欧美成人网在线综合视频 | av资源中文在线 | 麻豆精品传媒一二三区在线视频 | 成人午夜视频在线观看 | 亚洲视频在线观看免费视频 | 在线观看高清免费 | 91大神精品长腿在线观看网站 | 97国内精品久久久久久久影视 | 91传媒蜜桃香蕉在线观看 | 欧美激情久久久久久久久 | 亚洲国产天堂久久综合226 | 精品无人乱码高清 | 天天色天天 | 日韩视频在线观看 | 成人性a激情免费视频 | 91久久精品一区二区二区 | 精品视频一区二区三区免费 | 亚洲天堂在线电影 | 555夜色666夜色精品站 | 黄色片视频免费看 | 九九久久久 | 久久久国产视频 | 欧美特黄aaa| 久久69精品久久久久久国产越南 | 天堂最新在线资源 | 色婷婷综合缴情综六月 | 成人精品视频 |